Figure 2.

A. Longitudinal Random Forest Variable Importance for Fibrosis Progression: Training Cohort 

B. Longitudinal Random Forest Variable Importance for Clinical Outcomes: Training Cohort 

Accel, acceleration AFP, alpha-fetoprotein; ALT, alanine aminotransferase; Alk Phos, alkaline phosphatase; ANC, absolute neutrophil count; APRI, AST to platelet ratio index; AST, aspartate aminotransferase; CTP, Child-Turcotte-Pugh; Diff, differential; HOMA2 IR, homeostatic model assessment of insulin resistance; INR, international normalized ratio; MELD, model of end stage liver disease; WBC, white blood cell count